Cancers
iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers Nasdaq:ICAD
NASHUA, N.H., Oct. 16, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will host a technology innovation webinar on the current treatment landscape and unmet medical needs for treating cancer, on Wednesday, October 21, 2020, at 10am Eastern Time. …
Genetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System Cancers
BEIJING, Aug. 29, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, today announced its participation in the launch of a major national research project for early screening of lung and digestive system cancers led by …
Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers Nasdaq:AVCO
RNA-Based Chimeric Antigen Receptor (CAR) Design Compatible with Broad Range of Immune Effector Cells, Including T (CAR-T) and Natural Killer Cells (CAR-NK) Without the Use of Viral Vectors Capable of Targeting Multiple Tumor Antigens for Potentially Superior Therapeutic Effects Rapid 1-2 Day Bio-manufacturing Time to Quickly Meet Treatment Needs in Patients with Relapsed/Refractory Leukemia, Lymphoma …
Targeting Cancer’s Diversity and Evolution
Scientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells – opening up the potential to target proteins of this family to combat cancer’s diversity and evolution. A team at The Institute of Cancer Research, London, has discovered the three-dimensional structure and function of …